Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen‐independent prostate cancer cells
暂无分享,去创建一个
Vincenza Dolo | C. Vicentini | M. Bologna | V. Tombolini | D. Millimaggi | V. Dolo | Vincenzo Tombolini | G. Gravina | C. Festuccia | Giovanni Luca Gravina | Danilo Millimaggi | Claudio Festuccia | Carlo Vicentini | Mauro Bologna | Mariano de Vito | M. de Vito
[1] J. Herman,et al. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. , 1998, Cancer research.
[2] J. Isaacs,et al. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor , 2006, The Prostate.
[3] R. Vessella,et al. Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.
[4] P. Horák,et al. Promoter hypermethylation of GSTP1, AR, and 14‐3‐3σ in serum of prostate cancer patients and its clinical relevance , 2007, The Prostate.
[5] H. Parnes,et al. Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio. , 2004, The Journal of urology.
[6] M. Carducci,et al. Pharmacokinetics of 5-azacitidine administered with phenylbutyrate in patients with refractory solid tumors or hematologic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] E. Baldi,et al. Androgen receptor: good guy or bad guy in prostate cancer invasion? , 2003, Endocrinology.
[8] J T Arnold,et al. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. , 2002, Endocrine-related cancer.
[9] T. Visakorpi,et al. Androgen receptor gene and hormonal therapy failure of prostate cancer. , 1998, The American journal of pathology.
[10] M. Toyota,et al. Epigenetic Regulation of Androgen Receptor Gene Expression in Human Prostate Cancers , 2000, Laboratory Investigation.
[11] G. Bubley,et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.
[12] F. Cognetti,et al. Prostate cancer: the role of hormonal therapy. , 2005, Journal of experimental & clinical cancer research : CR.
[13] P. Spano,et al. Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145. , 2002, European journal of endocrinology.
[14] W. Isaacs,et al. Androgen receptor outwits prostate cancer drugs , 2004, Nature Medicine.
[15] A W Partin,et al. Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.